Oppenheimer Downgrades Edwards Lifesciences (EW) to Perform, 'Realizing LRP Challenging'
Tweet Send to a Friend
(Updated - October 8, 2025 6:02 AM EDT)
Oppenheimer analyst Suraj Kalia downgraded Edwards Lifesciences (NYSE: EW) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Suraj Kalia downgraded Edwards Lifesciences (NYSE: EW) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
